The National Cancer Institute (NCI) is offering a grant to support exploratory research projects aimed at developing innovative technologies to enhance the quality of biospecimens used in cancer research and clinical care. This grant focuses on addressing pre-analytical degradation issues during sample collection, processing, and storage, with the goal of improving downstream analyses. The grant will fund the development of tools, devices, and methods to preserve sample integrity and establish quality assessment criteria, ultimately advancing research in cancer biology, early detection, clinical diagnosis, and treatment. This opportunity is part of NCI’s broader Innovative Molecular Analysis Technologies (IMAT) Program.
Opportunity ID: 298895
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-18-004 |
| Funding Opportunity Title: | Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 – Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 20, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 28, 2018 |
| Current Closing Date for Applications: | Sep 28, 2018 |
| Archive Date: | Nov 03, 2018 |
| Estimated Total Program Funding: | $1,000,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Small businesses State governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments County governments Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. The overall goal is to support the development of highly innovative technologies capable of maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to preserve or protect sample integrity, or establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to accelerate and/or enhance research in cancer biology, early detection and screening, clinical diagnosis, treatment, epidemiology, or address issues associated with cancer health disparities, by reducing pre-analytical variations that affect biospecimen sample quality. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-004.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or after January 25, 2018 | PKG00236459 | Jan 28, 2018 | Sep 28, 2018 | View |
Package 1
Mandatory forms
298895 RR_SF424_2_0-2.0.pdf
298895 PHS398_CoverPageSupplement_4_0-4.0.pdf
298895 RR_OtherProjectInfo_1_4-1.4.pdf
298895 PerformanceSite_2_0-2.0.pdf
298895 RR_KeyPersonExpanded_2_0-2.0.pdf
298895 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
298895 RR_Budget_1_4-1.4.pdf
298895 RR_SubawardBudget30_1_4-1.4.pdf
298895 PHS398_ModularBudget_1_2-1.2.pdf
298895 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
